Want to see TSE:GREY full AI Analyst Report?
GREY Stock Chart & Stats
C$0.39
>-C$0.01(-1.27%)
At close: 4:00 PM EDT
C$0.39
>-C$0.01(-1.27%)
Day’s Range― - ―
52-Week RangeC$0.34 - C$0.90
Previous CloseN/A
Volume4.50K
Average Volume (3M)13.80K
Market Cap
C$3.12M
Enterprise ValueC$3.70
Total Cash (Recent Filing)C$210.03K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
Dec 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding8,923,237
10 Day Avg. Volume14,017
30 Day Avg. Volume13,803
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.77
Price to Sales (P/S)0.00
P/FCF Ratio-1.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.84
Revenue Forecast (FY)C$1.12M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA debt-free capital structure materially reduces fixed financial obligations and interest risk, improving strategic flexibility. Over 2-6 months this supports the company’s ability to prioritize R&D or product development without near-term default risk, easing capital-raising negotiations.
Narrowing Net LossMeaningful reduction in net losses signals improving cost structure or operating discipline rather than one-off effects. If sustained, this trend reduces future funding needs, extends runway and increases odds of reaching breakeven once revenue begins, a durable operational improvement.
Improving Cash BurnA materially lower cash burn rate is a structural improvement that extends runway and reduces immediate financing pressure. Sustained burn improvement indicates leaner operations and better cash management, increasing resilience during product development and commercialization phases.
Bears Say
No Revenue BaseAbsence of any reported revenue is a fundamental weakness: it leaves the business unproven commercially and forces continued reliance on capital markets. Without a revenue stream, long-term sustainability depends on successful product launches or persistent external funding.
Persistent Negative Cash FlowConsistently negative operating and free cash flow indicate the company is not self-funding its operations. This structural cash deficit increases dilution and refinancing risk over the medium term and constrains ability to scale or invest in go-to-market activities.
Volatile Equity & Negative ROEEroding equity and persistent negative returns on equity reflect value destruction and limited internal capital to fund growth. Over months this raises governance and dilution concerns, and reduces strategic optionality for acquisitions or large-scale investments.
Grey Matters Health News
GREY FAQ
What was Grey Matters Health’s price range in the past 12 months?
Grey Matters Health lowest stock price was C$0.34 and its highest was C$0.90 in the past 12 months.
What is Grey Matters Health’s market cap?
Grey Matters Health’s market cap is C$3.12M.
When is Grey Matters Health’s upcoming earnings report date?
Grey Matters Health’s upcoming earnings report date is Dec 18, 2026 which is in 136 days.
How were Grey Matters Health’s earnings last quarter?
Grey Matters Health released its earnings results on Jul 29, 2026. The company reported -C$0.13 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Grey Matters Health overvalued?
According to Wall Street analysts Grey Matters Health’s price is currently Overvalued.
Does Grey Matters Health pay dividends?
Grey Matters Health does not currently pay dividends.
What is Grey Matters Health’s EPS estimate?
Grey Matters Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Grey Matters Health have?
Grey Matters Health has 8,923,237 shares outstanding.
What happened to Grey Matters Health’s price movement after its last earnings report?
Grey Matters Health reported an EPS of -C$0.13 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.667%.
Which hedge fund is a major shareholder of Grey Matters Health?
Currently, no hedge funds are holding shares in TSE:GREY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Grey Matters Health
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Technical Analysis
Appili Therapeutics Inc Class A
―
Rakovina Therapeutics Inc
―
Universal Ibogaine Inc
―
Mindbio Therapeutics Corp.
―
Neural Therapeutics Inc.
―